BiotechTube

Vesicare

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Urinary Incontinence

Conditions

Urinary Incontinence

Trial Timeline

Oct 1, 2010 → May 1, 2013

NCT ID
NCT01215721

About Vesicare

Vesicare is a pre-clinical stage product being developed by Astellas Pharma for Urinary Incontinence. The current trial status is completed. This product is registered under clinical trial identifier NCT01215721. Target conditions include Urinary Incontinence.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (3)

NCT IDPhaseStatus
NCT01215721Pre-clinicalCompleted
NCT01489709Pre-clinicalCompleted
NCT00581061Pre-clinicalTerminated

Competing Products

20 competing products in Urinary Incontinence

See all competitors
ProductCompanyStageHype Score
Duloxetine + placeboEli LillyPhase 2
52
DuloxetineEli LillyPhase 2
52
Enfortumab vedotinAstellas PharmaPhase 1
33
solifenacin succinate + tamsulosin + placeboAstellas PharmaApproved
85
solifenacin succinate + tamsulosin hydrochloride + Placebo to solifenacin + Placebo to tamsulosinAstellas PharmaPhase 2
52
SolifenacinAstellas PharmaApproved
85
Mirabegron + Tolterodine + Placebo to Mirabegron + Placebo to TolterodineAstellas PharmaPhase 3
77
Levofloxacin + Solifenacin succinate + Placebo (for Solifenacin succinate)Astellas PharmaApproved
85
solifenacin succinateAstellas PharmaPhase 3
77
SolifenacinAstellas PharmaPre-clinical
23
SolifenacinAstellas PharmaPre-clinical
23
TamuslosinAstellas PharmaPhase 3
77
Tamsulosin + SolifenacinAstellas PharmaApproved
85
Alpha blocker + placebo + solifenacinAstellas PharmaApproved
85
mirabegron 25 mg + mirabegron 50 mg + solifenacin 5 mg + solifenacin 10 mg + mirabegron 25 mg matching placebo + mirabegron 50 mg matching placebo + solifenacin 5 mg matching placebo + solifenacin 10 mg matching placeboAstellas PharmaPhase 3
77
solifenacin succinate + tolterodineAstellas PharmaPhase 3
77
TamusulosinAstellas PharmaPhase 3
77
SolifenacinAstellas PharmaPre-clinical
23
Solifenacin succinate + TolterodineAstellas PharmaPhase 3
77
Solifenacin succinate + PlaceboAstellas PharmaPhase 3
77

Other Products from Astellas Pharma

Tacrolimus, Prograf®Approved
85
micafungin + voriconazoleApproved
85
mirabegron + solifenacinApproved
85
Zolpidem (Myslee®) + placeboApproved
85
TacrolimusApproved
85